CA2671029A1 - Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension - Google Patents

Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension Download PDF

Info

Publication number
CA2671029A1
CA2671029A1 CA2671029A CA2671029A CA2671029A1 CA 2671029 A1 CA2671029 A1 CA 2671029A1 CA 2671029 A CA2671029 A CA 2671029A CA 2671029 A CA2671029 A CA 2671029A CA 2671029 A1 CA2671029 A1 CA 2671029A1
Authority
CA
Canada
Prior art keywords
patient
treatment
pulmonary
left ventricular
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2671029A
Other languages
English (en)
French (fr)
Inventor
James S. Baldassarre
Ralf Rosskamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Hospital Products IP Unlimited Co
Original Assignee
Ikaria Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42062590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2671029(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ikaria Holdings Inc filed Critical Ikaria Holdings Inc
Priority to CA3130908A priority Critical patent/CA3130908A1/en
Publication of CA2671029A1 publication Critical patent/CA2671029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Clinical applications
    • A61B8/0883—Clinical applications for diagnosis of the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/104—Preparation of respiratory gases or vapours specially adapted for anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/135—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
    • A61M60/139—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting inside the aorta, e.g. intra-aortic balloon pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20—Type thereof
    • A61M60/295—Balloon pumps for circulatory assistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/40—Details relating to driving
    • A61M60/497—Details relating to driving for balloon pumps for circulatory assistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80—Constructional details other than related to driving
    • A61M60/841—Constructional details other than related to driving of balloon pumps for circulatory assistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80—Constructional details other than related to driving
    • A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
    • A61M60/857—Implantable blood tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q99/00—Subject matter not provided for in other groups of this subclass
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2201/00—Vessel construction, in particular geometry, arrangement or size
    • F17C2201/05—Size
    • F17C2201/058—Size portable (<30 l)
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2203/00—Vessel construction, in particular walls or details thereof
    • F17C2203/06—Materials for walls or layers thereof; Properties or structures of walls or their materials
    • F17C2203/0634—Materials for walls or layers thereof
    • F17C2203/0636—Metals
    • F17C2203/0646—Aluminium
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2221/00—Handled fluid, in particular type of fluid
    • F17C2221/01—Pure fluids
    • F17C2221/014—Nitrogen
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2221/00—Handled fluid, in particular type of fluid
    • F17C2221/03—Mixtures
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2223/00—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel
    • F17C2223/01—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel characterised by the phase
    • F17C2223/0107—Single phase
    • F17C2223/0123—Single phase gaseous, e.g. CNG, GNC
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2223/00—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel
    • F17C2223/03—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel characterised by the pressure level
    • F17C2223/036—Very high pressure (>80 bar)
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
    • F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
    • F17C2270/00—Applications
    • F17C2270/02—Applications for medical applications
    • F17C2270/025—Breathing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Artificial Intelligence (AREA)
  • Inorganic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Theoretical Computer Science (AREA)
  • General Business, Economics & Management (AREA)
CA2671029A 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension Abandoned CA2671029A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3130908A CA3130908A1 (en) 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49459809A 2009-06-30 2009-06-30
US12/494,598 2009-06-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3130908A Division CA3130908A1 (en) 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Publications (1)

Publication Number Publication Date
CA2671029A1 true CA2671029A1 (en) 2010-12-30

Family

ID=42062590

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2671029A Abandoned CA2671029A1 (en) 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
CA3130908A Pending CA3130908A1 (en) 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3130908A Pending CA3130908A1 (en) 2009-06-30 2009-07-02 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Country Status (7)

Country Link
US (12) US20100330206A1 (enExample)
EP (3) EP2269614A1 (enExample)
JP (3) JP2011010865A (enExample)
AU (3) AU2009202685B1 (enExample)
CA (2) CA2671029A1 (enExample)
MX (1) MX2010006055A (enExample)
WO (1) WO2011002606A1 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
JP2011010865A (ja) 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
JP2012100240A (ja) 2010-03-09 2012-05-24 Ricoh Co Ltd 画像処理装置、及び、画像処理方法
AU2011287948B2 (en) 2010-08-03 2014-11-06 G. Pohl-Boskamp Gmbh & Co. Kg Use of glyceryl trinitrate for treating traumatic edema
RU2495493C2 (ru) * 2010-10-25 2013-10-10 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет геодезии и картографии" (МИИГАиК) Способ прогнозирования риска смертности населения в зоне возникновения и нарастания концентрации загрязняющих веществ в атмосферном воздухе
CN103458951B (zh) 2011-01-06 2016-06-01 亿诺医疗公司 气体输送设备与系统
CA2827716C (en) 2011-02-25 2019-05-14 G. Pohl-Boskamp Gmbh & Co. Kg Stabilized granules containing glyceryl trinitrate
WO2012122096A2 (en) * 2011-03-04 2012-09-13 Sterling Point Research, Llc Systems and methods for optimizing medical care through data monitoring and feedback treatment
EP2713723B1 (en) * 2011-05-27 2018-09-12 Geno LLC Method of determining vasoreactivity using inhaled nitric oxide
FR2976260B1 (fr) * 2011-06-09 2013-07-05 Air Liquide Procede de conditionnement de melanges no/n2 avec etapes de purge et rincage gazeux prealable
FR2976259B1 (fr) * 2011-06-09 2013-07-05 Air Liquide Procede de conditionnement d'un melange gazeux no/n2
FR2976258B1 (fr) * 2011-06-09 2014-09-05 Air Liquide Installation de conditionnement de no a debitmetres massiques
FR2977298B1 (fr) * 2011-06-29 2015-02-06 Air Liquide Bouteille en aluminium pour melange gazeux no/azote
HK1198520A1 (en) 2011-11-07 2015-05-15 Mallinckrodt Hospital Products IP Limited Apparatus and method for monitoring nitric oxide delivery
US10426913B2 (en) 2011-11-07 2019-10-01 Mallinckrodt Hospital Products IP Limited Apparatus and method for monitoring nitric oxide delivery
ES2690398T3 (es) 2012-03-07 2018-11-20 Advanced Inhalation Therapies (Ait) Ltd. Inhalación de óxido nítrico para el tratamiento de enfermedades respiratorias
US8944051B2 (en) 2012-04-05 2015-02-03 Ino Therapeutics Llc Breathing apparatus detection and purging
FR2991026B1 (fr) * 2012-05-24 2014-07-04 Air Liquide Sante Int Conditionnement a haute pression d'un melange gazeux no/azote
FR2991025B1 (fr) * 2012-05-24 2014-07-04 Air Liquide Sante Int Conditionnement d'un melange gazeux no/azote a haute concentration en no
EP2668947B1 (en) 2012-05-31 2016-11-30 G. Pohl-Boskamp GmbH & Co. KG Induction of arteriogenesis with a nitric oxide-donor such as nitroglycerin
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
HUE032029T2 (en) 2012-12-04 2017-08-28 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
EP2964302A2 (en) 2013-03-07 2016-01-13 Advanced Inhalation Therapies (AIT) Ltd. Inhalation of nitric oxide for treating respiratory diseases
JP6654558B2 (ja) * 2013-03-13 2020-02-26 マリンクロット ホスピタル プロダクツ アイピー リミテッド 一酸化窒素の送達による治療の最中に酸素化を監視する装置および方法
CN109663193A (zh) 2013-03-15 2019-04-23 通用医疗公司 供吸入的一氧化氮气体的合成
CA2906660C (en) 2013-03-15 2021-05-25 The General Hospital Corporation Synthesis of nitric oxide gas for inhalation
CA2905994C (en) 2013-03-15 2022-01-04 Ino Therapeutics Llc Therapeutic gas delivery device with pulsed and continuous flow control
US9629358B2 (en) 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
ES2981406T3 (es) 2013-03-15 2024-10-08 Mallinckrodt Pharmaceuticals Ireland Ltd Administración y monitorización de óxido nítrico en fluidos ex vivo
US10342948B2 (en) 2013-03-18 2019-07-09 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
AU2014203438B2 (en) * 2013-06-25 2019-06-20 Mallinckrodt Hospital Products IP Limited Methods of reducing the risk of mortality associated with a medical treatment
US10512741B2 (en) 2013-09-13 2019-12-24 Mallinckrodt Hospital Products IP Limited Clinical decision support system and methods
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
US9381212B2 (en) * 2014-01-10 2016-07-05 Mallinckrodt Hospital Products IP Limited Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
US10188822B2 (en) 2014-03-13 2019-01-29 Mallinckrodt Hospital Products IP Limited Gas delivery device and system for use in magnetic resonance imaging
US10226592B2 (en) 2014-04-01 2019-03-12 Mallinckrodt Hospital Product Ip Limited Systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement
US10071213B2 (en) 2014-05-02 2018-09-11 Mallinckrodt Hospital Products IP Limited Systems and method for delivery of therapeutic gas to patients, in need thereof, receiving breathing gas from a ventilator that varies at least pressure and/or flow using enhanced therapeutic gas (NO) flow measurement
JP7067925B2 (ja) 2014-05-09 2022-05-16 マリンクロット ホスピタル プロダクツ アイピー リミテッド 高度なガス源を関するシステム及び方法並びに／又は治療ガスの供給システム及び方法並びに／又は治療ガス供給の増強性能検証
US10384031B1 (en) 2014-06-20 2019-08-20 Mallinckrodt Hospital Products IP Limited Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient
JP6317206B2 (ja) * 2014-07-30 2018-04-25 日本光電工業株式会社 生体情報測定装置、作動方法、及びプログラム
US10758703B2 (en) 2014-10-17 2020-09-01 Mallinckrodt Hospital Products IP Limited Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness
CN107073239A (zh) 2014-10-20 2017-08-18 通用医疗公司 用于合成一氧化氮的系统和方法
CN107735135B (zh) 2015-04-02 2020-06-26 希尔－罗姆服务私人有限公司 用于呼吸装置的歧管
US10912872B2 (en) 2015-07-22 2021-02-09 Viaderm Llc Cardiac assist device
CA3000210A1 (en) 2015-10-01 2017-04-06 Mallinckrodt Hospital Products IP Limited Device and method for diffusing high concentration no with inhalation therapy gas
DK3410927T3 (da) 2016-02-02 2022-03-14 Mallinckrodt Pharmaceuticals Ireland Ltd Kompensering for afbrydelser af måling af åndedrætsgasgennemstrømning
CN108883126B (zh) * 2016-02-12 2024-10-01 马林克罗特医疗产品知识产权公司 使用左心室辅助装置的情况下使用和监测吸入一氧化氮
JP2019515709A (ja) 2016-03-25 2019-06-13 ザ ジェネラル ホスピタル コーポレイション 窒化物の電気的プラズマ合成のための送達システム及び方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
KR102354762B1 (ko) 2017-02-27 2022-01-25 써드 폴, 아이엔씨. 산화 질소 발생 시스템 및 방법
EP4095094A1 (en) 2017-02-27 2022-11-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
CN110475562A (zh) 2017-03-31 2019-11-19 通用医疗公司 用于冷却一氧化氮发生器的系统和方法
WO2019046413A1 (en) * 2017-08-30 2019-03-07 Bellerophon Pulse Technologies Llc USE OF INHALED NITRIC OXIDE FOR ENHANCED RIGHT AND / OR LEFT VENTRICULAR FUNCTION
US11413445B2 (en) * 2019-03-12 2022-08-16 Heartware, Inc. Method of monitoring health conditions of a patient having an implantable blood pump
CN114375284A (zh) 2019-05-15 2022-04-19 第三极股份有限公司 用于生成一氧化氮的系统和方法
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
WO2020245573A1 (en) * 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
JP2024534608A (ja) 2021-09-23 2024-09-20 サード ポール，インコーポレイテッド 一酸化窒素を送達するシステム及び方法
USD1061594S1 (en) 2023-02-14 2025-02-11 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1064285S1 (en) 2023-02-14 2025-02-25 Mallinckrodt Pharmaceuticals Ireland Limited Therapeutic gas delivery cart
USD1092742S1 (en) 2023-02-14 2025-09-09 Mallinckrodt Pharmaceuticals Ireland Limited Therapeutic gas cylinder bay
USD1073017S1 (en) 2023-02-14 2025-04-29 Mallinckrodt Pharmaceuticals Ireland Limited Gas cylinder
USD1060405S1 (en) 2023-02-14 2025-02-04 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1069817S1 (en) 2023-02-14 2025-04-08 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1092732S1 (en) 2023-02-14 2025-09-09 Mallinckrodt Pharmaceuticals Ireland Limited Injector module
USD1087129S1 (en) 2023-02-14 2025-08-05 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1081795S1 (en) 2023-08-15 2025-07-01 Becton, Dickinson And Company Medical device label
USD1084322S1 (en) 2023-08-15 2025-07-15 Becton, Dickinson And Company Disinfecting unit label for a medical device
CN117815534A (zh) * 2023-12-12 2024-04-05 苏州晟智医疗科技有限公司 反搏辅助装置、计算设备、存储介质及反搏系统

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133584D1 (de) 1990-12-05 2007-12-13 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefässverengung und von Asthma
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
FR2695831B1 (fr) 1992-09-24 1994-11-10 Air Liquide Installation et procédé de fourniture d'un mélange gazeux aux voies respiratoires d'un utilisateur.
US5670125A (en) 1993-09-30 1997-09-23 The Boc Group, Inc. Process for the purification of nitric oxide
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
US5514204A (en) 1994-07-07 1996-05-07 The Boc Group, Inc. Process for the purification of nitric oxide
US5417950A (en) 1994-07-07 1995-05-23 The Boc Group, Inc. Process for the purification of nitric oxide
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5670127A (en) 1995-09-26 1997-09-23 The Boc Group, Inc. Process for the manufacture of nitric oxide
US5699790A (en) 1996-03-21 1997-12-23 Ohmeda Inc. System for predicting NO2 concentrations
US5692495A (en) 1996-04-02 1997-12-02 The Boc Group, Inc. Method and apparatus for the production of nitric oxide gas mixture
DK0914103T3 (da) 1996-04-05 2006-10-23 Gen Hospital Corp Behandling af hæmoglobinopati
US5732694A (en) 1996-12-13 1998-03-31 Ohmeda Inc. System for correcting NO2 monitor
US5732693A (en) 1996-10-02 1998-03-31 Ohmeda Inc. Pause control of nitric oxide therapy
US5752504A (en) 1996-12-13 1998-05-19 Ohmeda Inc. System for monitoring therapy during calibration
US5890490A (en) 1996-11-29 1999-04-06 Aylsworth; Alonzo C. Therapeutic gas flow monitoring system
US6259654B1 (en) 1997-03-28 2001-07-10 Telaric, L.L.C. Multi-vial medication organizer and dispenser
DE59813457D1 (de) 1997-01-17 2006-05-11 Ino Therapeutics Gmbh Brunn Am Gesteuertes gasversorgungssystem
US5918596A (en) 1997-04-22 1999-07-06 Instrumentarium Corp. Special gas dose delivery apparatus for respiration equipment
US6164276A (en) 1997-05-16 2000-12-26 Datex-Ohmeda, Inc. Accurate dose nitric oxide pulse delivery device with monitoring and alarms
US6125846A (en) 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
US5846973A (en) 1997-05-23 1998-12-08 Eli Lilly And Company Methods of treating pulmonary hypertension
US6109260A (en) 1998-02-18 2000-08-29 Datex-Ohmeda, Inc. Nitric oxide administration device with timed pulse
US6142147A (en) 1998-03-31 2000-11-07 The General Hospital Corporation Nasal delivery system for inhaled nitric oxide
US6089229A (en) 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US6581599B1 (en) 1999-11-24 2003-06-24 Sensormedics Corporation Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
WO2002040914A2 (en) 2000-11-17 2002-05-23 Controlink, Llc. Valve with handle including sensors and memory
ATE413883T1 (de) 2001-06-21 2008-11-15 Beth Israel Hospital Kohlenmonoxid verbessert die ergebnisse bei gewebe- und organtransplantationen und unterdrückt apoptose
CA2459891C (en) 2001-09-05 2014-02-04 Cyterra Corporation Method and apparatus for nitric oxide generation
BRPI0307673A2 (pt) 2002-02-13 2016-11-08 Beth Israel Hospital métodos de tratar doença vascular.
JP4588325B2 (ja) 2002-04-15 2010-12-01 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション イレウスの治療方法
AU2003223562B2 (en) 2002-04-15 2009-04-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
DK1505990T3 (da) 2002-05-17 2011-11-21 Univ Yale Fremgangsmåder til behandling af hepatitis
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
US20040106954A1 (en) 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
CN1898394B (zh) 2003-11-14 2012-05-30 科学工业研究委员会 检测高原肺水肿易感性的方法
EP1737482A4 (en) 2004-03-01 2010-09-15 Lumen Therapeutics Llc COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
WO2006053161A1 (en) 2004-11-09 2006-05-18 Cv Therapeutics, Inc. Use ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
JP2008523090A (ja) 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
EP1888049A2 (en) 2005-05-25 2008-02-20 The Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
CA2631740A1 (en) 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
WO2007067896A1 (en) 2005-12-05 2007-06-14 Ihc Intellectual Asset Management Llc Method for determining vasoreactivity
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US20080193566A1 (en) 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
WO2009048521A1 (en) 2007-10-11 2009-04-16 Duke University Potentiating the effect of compound comprising nitric oxide
US20090149541A1 (en) 2007-11-28 2009-06-11 Yafit Stark Method of delaying the onset of clinically definite multiple sclerosis
EP2315592A1 (en) 2008-08-13 2011-05-04 Novartis AG Treatment of pulmonary arterial hypertension
JP2011010865A (ja) 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法

Also Published As

Publication number Publication date
US20130078321A1 (en) 2013-03-28
US20140348955A1 (en) 2014-11-27
US8431163B2 (en) 2013-04-30
US20130040000A1 (en) 2013-02-14
US8795741B2 (en) 2014-08-05
US20140338665A1 (en) 2014-11-20
US8846112B2 (en) 2014-09-30
US20100330206A1 (en) 2010-12-30
EP2269614A1 (en) 2011-01-05
AU2010202422B2 (en) 2010-10-21
US20190231814A1 (en) 2019-08-01
EP2448572A1 (en) 2012-05-09
US20100331405A1 (en) 2010-12-30
WO2011002606A1 (en) 2011-01-06
US20140377378A1 (en) 2014-12-25
AU2010206032A1 (en) 2010-09-02
US20130068223A1 (en) 2013-03-21
US20100330207A1 (en) 2010-12-30
AU2009202685B1 (en) 2010-08-19
MX2010006055A (es) 2011-03-16
WO2011002606A8 (en) 2011-08-11
CA3130908A1 (en) 2010-12-30
US8282966B2 (en) 2012-10-09
US20100330193A1 (en) 2010-12-30
AU2010206032B2 (en) 2011-12-08
JP2011251155A (ja) 2011-12-15
JP2011011059A (ja) 2011-01-20
AU2010202422A1 (en) 2010-09-02
US8293284B2 (en) 2012-10-23
US20130074839A1 (en) 2013-03-28
JP2011010865A (ja) 2011-01-20
EP2540304A1 (en) 2013-01-02
US11931377B2 (en) 2024-03-19

Similar Documents

Publication Publication Date Title
US11931377B2 (en) Methods of administering inhaled nitric oxide gas
AU2016259420B2 (en) Methods of treating patients having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20211013

FZDE Discontinued

Effective date: 20211013